These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 23461220)

  • 1. [A study on clinical features of patients with benzodiazepines use disorder (BZsUD), and characteristics of psychiatric treatments which may cause BZsUD].
    Matsumoto T; Naruse N; Umeno M; Aoyama K; Kobayashi O; Shimane T; Morita N; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Dec; 47(6):317-30. PubMed ID: 23461220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current situation and clinical characteristics of sedative-related disorder patients in Japan: a comparison with methamphetamine-related disorder patients].
    Matsumoto T; Ozaki S; Kobayashi O; Wada K
    Seishin Shinkeigaku Zasshi; 2011; 113(12):1184-98. PubMed ID: 22352004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
    Tanibuchi Y; Matsumoto T; Kobayashi O; Wada K
    Seishin Shinkeigaku Zasshi; 2013; 115(5):463-76. PubMed ID: 23855225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacology of the anxiety disorders.
    Ballenger JC
    Psychiatr Clin North Am; 1984 Dec; 7(4):757-71. PubMed ID: 6151647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Description of medicosocial profiles of pharmacodependent subjects consulting addictology centres using a computerized database].
    Landreat MG; Vigneau CV; Bronnec MG; Sebille-Rivain V; Venisse JL; Jolliet P
    Encephale; 2011 Dec; 37(6):418-24. PubMed ID: 22137213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and suicide risk of outpatients at specialized hospitals for substance use disorder: comparison with depressive disorder patients at general psychiatric clinics.
    Matsumoto T; Matsushita S; Okudaira K; Naruse N; Cho T; Muto T; Ashizawa T; Konuma K; Morita N; Ino A
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2011 Dec; 46(6):554-9. PubMed ID: 22413563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine dependence of several years duration: clinical profile and therapeutic benefits.
    Tennant FS; Pumphrey EA
    NIDA Res Monogr; 1984; 55():211-6. PubMed ID: 6443381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine dependence: focus on withdrawal syndrome.
    Authier N; Balayssac D; Sautereau M; Zangarelli A; Courty P; Somogyi AA; Vennat B; Llorca PM; Eschalier A
    Ann Pharm Fr; 2009 Nov; 67(6):408-13. PubMed ID: 19900604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-morbid post-traumatic stress disorder in a substance misusing clinical population.
    Reynolds M; Mezey G; Chapman M; Wheeler M; Drummond C; Baldacchino A
    Drug Alcohol Depend; 2005 Mar; 77(3):251-8. PubMed ID: 15734225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The problems with the use of benzodiazepines in elderly patients].
    Bourin M
    Encephale; 2010 Sep; 36(4):340-7. PubMed ID: 20850606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abuse of benzodiazepines among heroin addicts in Copenhagen].
    Glyngdal P; Hansen K
    Ugeskr Laeger; 1997 Oct; 159(44):6523-7. PubMed ID: 9411972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse among first admissions to the psychiatric unit of a general hospital in Trinidad.
    Reid SD; Ramcharan C; Ghany K
    West Indian Med J; 2004 Mar; 53(2):95-9. PubMed ID: 15199719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders.
    Michelini S; Cassano GB; Frare F; Perugi G
    Pharmacopsychiatry; 1996 Jul; 29(4):127-34. PubMed ID: 8858711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Addiction in the elderly - an underestimated diagnosis in clinical practice?].
    Wetterling T; Backhaus J; Junghanns K
    Nervenarzt; 2002 Sep; 73(9):861-6. PubMed ID: 12215877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA systems, benzodiazepines, and substance dependence.
    Malcolm RJ
    J Clin Psychiatry; 2003; 64 Suppl 3():36-40. PubMed ID: 12662132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.